Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2018

Feb 16, 2018

30016_dirs_2018-02-16_af6c5e86-9132-45b4-987b-c1ff65001e4b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2018-02-14

Reporting Person: Studer Jacqueline (CVP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-14 Common Stock M 346 Acquired 4757 Direct
2018-02-14 Common Stock M 406 Acquired 5163 Direct
2018-02-14 Common Stock M 212 Acquired 5375 Direct
2018-02-14 Common Stock F 298 $178.26 Disposed 5077 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-14 Non-Qualified Stock Option (right-to-buy) $178.26 A 8007 Acquired 2028-02-13 Common Stock (8007) Direct
2018-02-14 Incentive Stock Option (right-to-buy) $178.26 A 560 Acquired 2028-02-13 Common Stock (560) Direct
2018-02-14 Restricted Stock Unit $ A 841 Acquired Common Stock (841) Direct
2018-02-14 Restricted Stock Unit $ M 346 Disposed Common Stock (346) Direct
2018-02-14 Restricted Stock Unit $ M 406 Disposed Common Stock (406) Direct
2018-02-14 Restricted Stock Unit $ M 212 Disposed Common Stock (212) Direct

Footnotes

F1: Includes a total of 72 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 29, 2017 and December 29, 2017.

F2: Closing price of Issuer's common stock on the NASDAQ market on February 14, 2018.

F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2019.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.

F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019.

F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018.

F9: Not applicable.